Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of 3.03 trillion as of September 15, 2025. Its market cap has decreased by -1.41% in one year.

Market Cap

3.03T

Enterprise Value

3.70T

Revenue

1.94T

Ranking

n/a

PE Ratio

37.24

Stock Price

1,691.00

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 3.03T, an increase of 242.82%. That is a compound annual growth rate of 3.73%.

Market Cap History

Date	Market Cap	% Change
Sep 12, 2025	3,026.52B	10.18%
Dec 30, 2024	2,746.92B	-9.13%
Dec 29, 2023	3,022.77B	-17.34%
Dec 30, 2022	3,657.07B	5.52%
Dec 30, 2021	3,465.82B	17.06%
Dec 30, 2020	2,960.81B	-15.46%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	11.02T
HOYA Corporation	7,255.12B
Takeda Pharmaceutical Company	7,018.04B
Daiichi Sankyo Company	6,559.74B
Otsuka Holdings	4,492.29B
Terumo	3,821.13B
Shionogi &	2,262.34B
Olympus	2,023.18B

Market Cap Rankings